Results 191 to 200 of about 166,548 (251)

Cross‐protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies

Equine Veterinary Journal, EarlyView.
Abstract Background Streptococcus equi subspecies zooepidemicus is a highly diverse opportunistic pathogen of horses, associated with respiratory disease and endometritis. Objectives To characterise S. zooepidemicus isolates recovered from young ponies during a natural episode of respiratory disease, and to determine if vaccination with Strangvac®, a ...
Romain Paillot, J. Richard Newton, Sonia Gonzalez Medina, Sara Frosth, Lars Frykberg, Margareta Flock, Bengt Guss, Jan‐Ingmar Flock, Andrew S. Waller   +8 more
wiley   +1 more source

From Jenner to genomics: the unfolding future of vaccinology. [PDF]

Front Immunol
Batool R.
europepmc   +1 more source

Genetic variants of EcPV2 E6 and E7 in equine genital and oronasal squamous cell carcinoma

Equine Veterinary Journal, EarlyView.
Abstract Background Since its discovery in 2008, equine papillomavirus type 2 (EcPV2) has been detected in up to 100% of equine genital and up to 40% of equine oronasal squamous cell carcinomas (SCCs). Preliminary sequence data point to the existence of EcPV2 E6 and E7 oncogene variants compared to the British reference sequence from 2008.
Maya Jenner, Sabine Brandt
wiley   +1 more source

Update on efficacy, safety, and immunogenicity of Dengue vaccines: a systematic review and meta-analysis. [PDF]

Infez Med
Zaçe D, Çekrezi A, Leone M, Ciarpaglini S, Montagnari G, Giacalone ML, Diforti S, Rodriguez-Morales AJ, Iannetta M, Sarmati L.   +9 more
europepmc   +1 more source

Engineering mRNA‐LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases

Exploration, EarlyView.
This review highlights recent advances in engineering messenger RNA (mRNA)‐lipid nanoparticles (LNPs) to cross the ageing blood–brain barrier and target neurodegenerative diseases. It outlines design principles, delivery routes, and translational challenges, charting a roadmap towards clinical application of mRNA‐LNP therapeutics for neurodegenerative ...
Abdel Ali Belaidi, Denzil L. Furtado, Francesca Alves, Rebecca M. Nisbet, Scott Ayton, Ashley I. Bush   +5 more
wiley   +1 more source

<i>Helicobacter pylori</i> vaccines: from bench to bedside-progress, challenges, and future directions. [PDF]

Front Immunol
Wang S, Yang Y, Ma C, Guo L.
europepmc   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

FlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu, Yubing Hu, Dong Wang, Ben Zhong Tang   +3 more
wiley   +1 more source

Monkeypox Virus Countermeasures: Vaccines, Antibodies, Drugs and Traditional Chinese Medicine. [PDF]

Drug Des Devel Ther
Xu X, Nie Y, Zhang Y, Liu J.
europepmc   +1 more source

Development of an mRNA vaccine against the OprF of <i>Pseudomonas aeruginosa</i> and evaluation of antibody response in mouse. [PDF]

Microbiol Spectr
Fathi M, Lotfollahi L, Mehravar F, Nomanpour B.   +3 more
europepmc   +1 more source

The current landscape and future directions of Lyme disease vaccines. [PDF]

Virulence
Chen Z, He L, Huang X, Liang X, Liu A, Bao F.   +5 more
europepmc   +1 more source